The US Food and Drug Administration UU. In said Johnson & Johnson, it must discard millions of doses of its VACCO-19 vaccine that were manufactured in a Baltimore factory plagued by problems, but it was also eliminated from the millions of people.
Two sources familiar with the situation told Reuters that the agency had clarified about 10 million doses. The New York Times said that the batches that are discarded amount to around 60 million doses, citing people familiar with the matter.
Without revealing or confirming the number of vaccine doses, the FDA said at a news launch that had authorized two lots of the vaccine for use, which several other lots were not suitable for use and that others were being evaluated.
The agency said that it was not yet ready to authorize the Emergency Biosolutions Inc plant for the manufacture of the J & J vaccine. The production of the J & J vaccine at the Baltimore site was arrested by the United States authorities In April and J & J was in charge of manufacturing on the plant.
A source familiar with the matter told Reuters that the doses of J & J are expected to be exported to other countries. The doses are already in vials and lists for use, said the other source.
